Anti-obesity effect of 6,8-diprenylgenistein, an isoflavonoid of Cudrania tricuspidata fruits in high-fat diet-induced obese mice

Nutrients

Volumn 7, Issue 12, 2015, Pages 10480-10490

  Jo, Yang Hee ^a   Choi, Kyeong Mi ^a   Liu, Qing ^a   Kim, Seon Beom ^a   Ji, Hyeong Jin ^a   Kim, Myounghwan ^a   Shin, Sang Kyung ^a   Do, Seon Gil ^b   Shin, Eunju ^b   Jung, Gayoung ^b   Yoo, Hwan Soo ^a   Hwang, Bang Yeon ^a   Lee, Mi Kyeong ^a  

^a Chungbuk National University   (South Korea)

^b Univera Inc   (South Korea)

Author keywords

6,8 Diprenylgenistein (DPG); AMPK; Cudrania tricuspidata; High fat diet induced obesity; Lipid profile

Indexed keywords

6,8 DIPRENYLGENISTEIN; ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CCAAT ENHANCER BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOFLAVONOID; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; 6,8-DIPRENYLGENISTEIN; ANTIOBESITY AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; GENISTEIN; ISOFLAVONE DERIVATIVE;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTI OBESITY ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; CUDRANIA TRICUSPIDATA; DRUG ACTIVITY; FOOD INTAKE; FRUIT; HISTOPATHOLOGY; IMAGE ANALYSIS; LIPID DIET; LIPID STORAGE; LIVER DYSFUNCTION; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OBESITY; WESTERN BLOTTING; ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MORACEAE; MOUSE MUTANT;

ACETYL-COA CARBOXYLASE; ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DIET, HIGH-FAT; FRUIT; GENE EXPRESSION REGULATION; GENISTEIN; HYDROXYMETHYLGLUTARYL COA REDUCTASES; ISOFLAVONES; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MORACEAE; OBESITY; PLANT EXTRACTS; PPAR GAMMA;

EID: 84949999873     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7125544     Document Type: Article

References (36)

1. Kopelman, P.G. Obesity as a medical problem. Nature 2000, 404, 635–643. [PubMed]
2. Visscher, T.L.; Seidell, J.C. The public health impact of obesity. Ann. Rev. Public Health 2001, 22, 355–375. [CrossRef] [PubMed]
3. Yun, J.W. Possible anti-obesity therapeutics from nature—A review. Phytochemistry 2010, 71, 1625–1641. [CrossRef] [PubMed]
4. Farmer, S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4, 263–273. [CrossRef] [PubMed]
5. Maffei, M.; Halaas, J.; Ravussin, E.; Pratley, R.E.; Lee, G.H.; Zhang, Y. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1995, 1, 1155–1161. [CrossRef] [PubMed]
6. Ruderman, N.B.; Carling, D.; Prentki, M.; Cacicedo, J.M. AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Investig. 2013, 123, 2764–2772. [CrossRef] [PubMed]
7. Hardie, D.G. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim. Biophys. Acta 1992, 1123, 231–238. [CrossRef]
8. Legeay, S.; Rodier, M.; Fillon, L.; Faure, S.; Clere, N. Epigallocatechin gallate: A review of its beneficial properties to prevent metabolic syndrome. Nutrients 2015, 7, 5443–5468. [CrossRef] [PubMed]
9. Choi, K.M.; Jeon, Y.S.; Kim, W.; Lee, A.; Kim, Y.G.; Lee, J.H.; Kang, Y.E.; Jung, J.C.; Lee, J.; Min, B., et al. Xanthigen attenuates high-fat diet-induced obesity through down-regulation of PPAR and activation of the AMPK pathway. Food Sci. Biotechnol. 2014, 23, 931–935 [CrossRef]
10. Choi, K.M.; Lee, Y.S.; Kim, W.; Kim, S.J.; Shin, K.O.; Yu, J.Y.; Lee, M.K.; Lee, Y.M.; Hong, J.T.; Yun Y.P., et al. Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice. J. Nutr. Biochem. 2014, 25, 201–207. [CrossRef] [PubMed]
11. Ahn, J.H.; Kim, E.S.; Lee, C.; Kim, S.; Cho, S.H.; Hwang, B.Y.; Lee, M.K. Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects. Bioorg. Med. Chem. Lett. 2013, 23, 3604–3608. [CrossRef] [PubMed]
12. Buchholz, T.; Melzig, M.F. Polyphenolic compounds as pancreatic lipase inhibitors. Planta Med. 2015, 81, 771–783. [CrossRef] [PubMed]
13. Senaphan, K.; Kukongviriyapan, U.; Sangartit, W.; Pakdeechote, P.; Pannangpetch, P.; Prachaney, P.; Greenwald, S.E.; Kukongviriyapan, V. Ferulic acid alleviates changes in a rat model of metabolic syndrome induced by high-carbohydrate, high-fat diet. Nutrients 2015, 7, 6446–6464. [CrossRef] [PubMed]
14. Kawakami, Y.; Kiyosawa, T.; Nakamura, S.; Osada, K. Effects of isoflavone supplementation on disturbances in lipid metabolism and antioxidant system due to exogenous cholesterol oxidation products in rats. J. Funct. Foods 2014, 7, 212–218. [CrossRef]
15. Lee, H.; Ha, H.; Lee, J.K.; Seo, C.S.; Lee, N.H.; Jung, D.Y.; Park, S.J.; Shin, H.K. The fruits of Cudrania tricuspidata suppress development of atopic dermatitis in NC/Nga mice. Phytother. Res. 2012, 26, 594–599. [CrossRef] [PubMed]
16. Han, X.H.; Hong, S.S.; Jin, Q.; Li, D.; Kim, H.K.; Lee, J.; Kwon, S.H.; Lee, D.; Lee, C.K.; Lee, M.K., et al. Prenylated and benzylated flavonoids from the fruits of Cudrania tricuspidata. J. Nat. Prod. 2009, 72, 164–167. [CrossRef] [PubMed]
17. Cho, E.J.; Yokozawa, T.; Rhyu, D.Y.; Kim, S.C.; Shibahara, N.; Park, J.C. Study on the inhibitory effects of Korean medicinal plants and their main compounds on the 1,1-diphenyl-2-picrylhydrazyl radical. Phytomedicine 2003, 10, 544–551. [CrossRef] [PubMed]
18. Jeong, J.Y.; Jo, Y.H.; Lee, K.Y.; Do, S.G.; Hwang, B.Y.; Lee, M.K. Optimization of pancreatic lipase inhibition by Cudrania tricuspidata fruits using response surface methodology. Bioorg. Med. Chem. Lett. 2014, 24, 2329–2333. [CrossRef] [PubMed]
19. Oh, W.K.; Lee, C.H.; Seo, J.H.; Chung, M.Y.; Cui, L.; Fomum, Z.T.; Kang, J.S.; Lee, H.S. Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis. Arch. Pharm. Res. 2009, 32, 43–47. [CrossRef] [PubMed]
20. Fowler, S.D.; Greenspan, P. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: Comparison with oil red O. J. Histochem. Cytochem. 1985, 33, 833–836. [CrossRef] [PubMed]
21. White, U.A.; Stephens, J.M. Transcriptional factors that promote formation of white adipose tissue. Mol. Cell Endocrinol. 2010, 318, 10–14. [CrossRef] [PubMed]
22. Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85–97. [CrossRef] [PubMed]
23. Rajala, M.W.; Scherer, P.E. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144, 3765–3773. [CrossRef] [PubMed]
24. Tobert, J.A. Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat. Rev. Drug Discov. 2003, 2, 517–526. [CrossRef] [PubMed]
25. Choi, K.M.; Lee, Y.S.; Shin, D.M.; Lee, S.; Yoo, K.S.; Lee, M.K.; Lee, J.H.; Kim, S.Y.; Lee, Y.M.; Hong, J.T., et al. Green tomato extract attenuates high-fat-diet-induced obesity through activation of the AMPK pathway in C57BL/6 mice. J. Nutr. Biochem. 2013, 24, 335–342. [CrossRef] [PubMed]
26. Bhaswant, M.; Poudyal, H.; Mathai, M.L.; Ward, L.C.; Mouatt, P.; Brown, L. Green and black cardamom in a diet-induced rat model of metabolic syndrome. Nutrients 2015, 7, 7691–7707. [CrossRef] [PubMed]
27. Aguirre, L.; Fernández-Quintela, A.; Arias, N.; Portillo, P.P. Resveratrol: Anti-obesity mechanisms of action. Molecules 2014, 19, 18632–18655. [CrossRef] [PubMed]
28. Okuda, M.H.; Zemdegs, J.C.S.; Santana, A.A.; Santamarina, A.B.; Moreno, M.F.; Hachul, A.C.L.; Santos, B.; Nascimento, O.; Ribeiro, E.B.; Oyama, L.M. Green tea extract improves high fat diet-induced hypothalamic inflammation, without affecting serotoninergic system. J. Nutr. Biochem. 2014, 25, 1084–1089. [CrossRef] [PubMed]
29. Sclafani, A.; Springer, D. Dietary obesity in adult rats: Similarities to hypothalamic and human obesity syndromes. Physiol. Behav. 1976, 17, 461–471. [CrossRef]
30. Ntambi, J.M.; Young-Cheul, K. Adipocyte differentiation and gene expression. J. Nutr. 2000, 130, 3122-3126. [PubMed]
31. Tong, Q.; Hotamisligil, G.S. Molecular mechanisms of adipocyte differentiation. Rev. Endocr. Metab. Disord. 2001, 2, 349–355. [CrossRef] [PubMed]
32. Nedvidkova, J.; Smitka, K.; Kopsky, V.; Hainer, V. Adiponectin, an adipocyte-derived protein. Physiol. Res. 2005, 54, 133–140. [PubMed]
33. Diez, J.J.; Iglesias, P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003, 148, 293–300. [CrossRef] [PubMed]
34. Carling, D.; Zammit, V.A.; Hardie, D.G. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 1987, 223, 217–222. [CrossRef]
35. Steinberg, G.R.; Kemp, B.E. AMPK in health and disease. Physiol. Rev. 2008, 89, 1025–1078. [CrossRef] [PubMed]
36. Behloul, N.; Wu, G. Genistein: A promising therapeutic agent for obesity and diabetes treatment. Eur. J. Pharmacol. 2013, 698, 31–38. [CrossRef] [PubMed]